The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients.
FDA upgrades recall on 160,000+ bottles of thyroid medication
© 2024 SheSpeaks.ca - Your Voice, Your Story.